ArticleACR open rheumatology2024

Improvements in Patient-Reported Outcomes Through Six Months of Guselkumab Treatment in Patients With Active Psoriatic Arthritis: Real-World Data From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.

Philip J Mease et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.